Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Polaris Chemicals is an Italian contract development and manufacturing organization (CDMO) specializing in the production of active pharmaceutical ingredients (APIs) and advanced intermediates. Founded in 1970 and headquartered in Crespellano, Italy, the company was acquired by Minakem (a subsidiary of the Minafin Group) in 2021. Polaris Chemicals is recognized for its expertise in complex chemical synthesis, particularly in organometallic chemistry and high-pressure hydrogenation. The company operates a GMP-certified facility that supports pharmaceutical clients from the development phase through to commercial-scale production. Their services include process optimization, scale-up, and the manufacturing of high-quality chemical components for the global life sciences industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Polaris Chemicals.